Finzati - Logo
LIFD logo

LFTD Partners Inc.

LIFD • Drug Manufacturers - Specialty & Generic
$0.10
— 0.00 (0.00%)
Current price
EarningsLatest report: Mar 31, 2026
BALANCED PROFILENeutralConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Mixed profile. The company is not automatically unattractive, but valuation, growth, or balance-sheet evidence does not yet justify a stronger signal.
Market Cap
$1.48M
Growth
—
Cash Flow
3/5
Trend
Mostly stable
Evidence
Positive free cash flow · 80946.1Manageable debt level · 0.14Healthy liquidity · 3.04Weak profitability
Financial data as of: Mar 31, 2026, 12:00 AM UTCLast earnings update: May 15, 2026, 12:00 AM UTCLast profile update: Aug 5, 2026, 2:27 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$0.10
Change0.00%
Shares Out14.82M
Market Cap$1.48M
Enterprise Value$226.88K
52W Range0.11 - 0.39
Beta1.55
P/E-0.05
P/S0.04
P/B0.18
P/FCF-0.00
EV/Sales0.01

Investment DNA

How strong this company looks for long-term investors

61
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
71/100
Growth Potential
Revenue and expansion
58/100
Price Attractiveness
Cheap or expensive today
95/100
Why this score▼
Positive free cash flow · 80946.1Manageable debt level · 0.14Healthy liquidity · 3.04Weak profitability
Analyst view
No analyst data available now.

Company Overview

IPO: 9/27/2012
Industry: Drug Manufacturers - Specialty & Generic
P/B i: 0.18
Debt / Equity i: 0.14
Operating Margin: 2.47%
Net Margin: -67.33%
ROE i: -
ROIC: -

Financial Health

Score14 / 20
Debt / Equity: 0.14
Current Ratio: 3.04
Quick Ratio: 0.92
Status: Good

Insider Transactions

Recent executive and insider activity

JACOBS GERARD M.
Transaction: 11/15/2023
BUY
Change
+375
Price
$1.50
Filing
11/21/2023
Type
BUY